Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

92.08

+3.69 (4.17%)

At close: Feb 27, 2026, 4:00 PM EST

92.09

+0.01 (0.01%)

After-hours: Feb 27, 2026, 5:48 PM EST

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.39	97.25	186.73	125.74	123.67
Short-Term Investments	438.97	321.66	154.89	111.61	203.24
Cash & Short-Term Investments	567.36	418.91	341.62	237.36	326.9
Cash Growth	35.44%	22.63%	43.93%	-27.39%	6.90%
Accounts Receivable	0.12	165	10	0.01	1.57
Other Receivables	4.38	3.49	0.33	0.04	3.77
Receivables	4.5	168.49	10.33	0.05	5.33
Prepaid Expenses	5.71	4.24	3.63	5.67	8.5
Total Current Assets	577.57	591.64	355.58	243.08	340.74
Property, Plant & Equipment	11.69	12.61	2.15	4.63	6.73
Long-Term Investments	78.64	140.25	-	-	-
Other Long-Term Assets	0.29	0.23	0.23	0.23	0.23
Total Assets	668.19	744.73	357.95	247.93	347.7
Accounts Payable	5.34	1.62	0.77	3.64	1.6
Accrued Expenses	28.08	23.62	19.26	24.54	37.31
Current Portion of Leases	2.28	0.51	1.14	2.52	2.2
Current Income Taxes Payable	-	2.69	-	-	-
Current Unearned Revenue	9.55	18.89	-	-	1.6
Other Current Liabilities	0.19	0.07	0.1	0.48	1.31
Total Current Liabilities	45.44	47.4	21.27	31.18	44.02
Long-Term Leases	8.04	10.36	-	1.14	3.66
Long-Term Unearned Revenue	-	11.68	-	-	-
Total Liabilities	53.48	69.43	21.27	32.32	47.67
Common Stock	0	0	0	-	-
Additional Paid-In Capital	1,085	1,016	952.49	752.72	709.68
Retained Earnings	-470.67	-340.52	-615.71	-536.76	-409.36
Comprehensive Income & Other	0.64	-0.08	-0.11	-0.36	-0.3
Total Common Equity	614.71	675.3	336.68	215.61	300.02
Shareholders' Equity	614.71	675.3	336.68	215.61	300.02
Total Liabilities & Equity	668.19	744.73	357.95	247.93	347.7
Total Debt	10.32	10.87	1.14	3.66	5.86
Net Cash (Debt)	635.68	548.3	340.48	233.7	321.04
Net Cash Growth	15.94%	61.04%	45.69%	-27.21%	6.36%
Net Cash Per Share	10.00	8.43	6.00	4.77	6.93
Filing Date Shares Outstanding	63.81	61.38	58.27	51.28	48.41
Total Common Shares Outstanding	62.58	61.04	57.71	49.34	47.84
Working Capital	532.13	544.24	334.3	211.9	296.72
Book Value Per Share	9.82	11.06	5.83	4.37	6.27
Tangible Book Value	614.71	675.3	336.68	215.61	300.02
Tangible Book Value Per Share	9.82	11.06	5.83	4.37	6.27
Machinery	9.24	7.8	6.47	5.91	5.18
Leasehold Improvements	2.94	2.42	0.96	0.91	0.88

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q